FDA proposes rule to end «self-affirmed» GRAS rule in 2026
The US Food and Drug Administration has added a proposed rule to its spring 2026 agenda that would eliminate the current provision of companies self-affirming their ingredients as safe.
The proposal would force companies to submit GRAS notices for food ingredients for FDA review, eliminating the self-affirmation process that many companies currently use to enter the market. The latter pathway allows manufacturers to independently determine their ingredients as safe for use, which RFK Jr has called the provision a «loophole».